The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.

Abstract

Respiratory syncytial virus (RSV) is a major cause of morbidity in infants, young children, and the elderly worldwide. Presently, there are no explicit recommendations for RSV treatment apart from supportive care. Recent progress in studies of the mechanism of RNA interference suggests the formation of a new class of antiviral drugs in the treatment of RSV infection and related respiratory diseases.

Keywords

• респираторный синцитиальный вирус
• малые интерферирующие рнк
• рнк- интерференция